| Autor: |
Evette B. M. Hillman, Sjoerd Rijpkema, Danielle Carson, Ramesh P. Arasaradnam, Elizabeth M. H. Wellington, Gregory C. A. Amos |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Microbiology Research, Vol 12, Iss 2, Pp 335-353 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2036-7481 |
| DOI: |
10.3390/microbiolres12020023 |
| Popis: |
Bile acid diarrhoea (BAD) is a widespread gastrointestinal disease that is often misdiagnosed as irritable bowel syndrome and is estimated to affect 1% of the United Kingdom (UK) population alone. BAD is associated with excessive bile acid synthesis secondary to a gastrointestinal or idiopathic disorder (also known as primary BAD). Current licensed treatment in the UK has undesirable effects and has been the same since BAD was first discovered in the 1960s. Bacteria are essential in transforming primary bile acids into secondary bile acids. The profile of an individual’s bile acid pool is central in bile acid homeostasis as bile acids regulate their own synthesis. Therefore, microbiome dysbiosis incurred through changes in diet, stress levels and the introduction of antibiotics may contribute to or be the cause of primary BAD. This literature review focuses on primary BAD, providing an overview of bile acid metabolism, the role of the human gut microbiome in BAD and the potential options for therapeutic intervention in primary BAD through manipulation of the microbiome. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
